People

Ulf Grawunder

biomedvc.comlinkedin.com

Ulf Grawunder was appointed an entrepreneur in residence at BiomedVC in April 2026. He co-founded and leads T-CURX and previously built 4-Antibody and NBE-Therapeutics. He trained in biochemistry and immunology and earned his doctorate at the University of Basel. These are institutional manager affiliations; no personal portfolio investment is inferred.